Moffitt Researchers Identify Tumor-Based Methylation Patterns as Cancer Biomarkers

In a new study featured on the cover of the May 1 issue of the journal Cancer Research, Moffitt Cancer Center researchers report on their identification of biomarkers based on a type of genetic modification called methylation that predicts the type...
18-May-2022 8:05 AM EDT Add to Favorites

Moffitt Researchers Identify Pathway that Regulates Lipid Synthesis and Contributes to Tumor Survival

In a new study published in the journal Cell Reports, Moffitt Cancer Center researchers show that cancer cells in an acidic environment undergo lipid synthesis and accumulation. The team identified the key signaling molecules responsible for these...
10-May-2022 11:20 AM EDT Add to Favorites

Moffitt Researchers Identify Key Factors Impacting Adaptive Therapy

Researchers in the Center of Excellence for Evolutionary Therapy at Moffitt Cancer Center have been investigating an alternative treatment approach called adaptive therapy that focuses on maintaining disease control instead of complete tumor cell...
9-May-2022 11:25 AM EDT Add to Favorites

Moffitt Researchers Discover New Target for CAR T Cells in Solid Tumors

In a new study published in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research, Moffitt Cancer Center researchers share the identification of a new potential target for CAR T cells called OR2H1 that they have...
4-May-2022 10:05 AM EDT Add to Favorites

Moffitt Researchers Develop Model to Predict Patients with Poor Lung Cancer Outcomes

Moffitt Cancer Center researchers are working to improve the ability to identify patients who are at a higher risk of poor survival through radiomics, an area of science that uses imaging, such as CT scans and MRIs, to uncover tumoral patterns and...
27-Apr-2022 9:40 AM EDT Add to Favorites

Moffitt Researchers Identify Key Characteristics of Immune Cells in Ovarian Cancer

Researchers at Moffitt Cancer Center want to improve their understanding of the immune environment in ovarian cancer in hopes of making immunotherapy an option for these patients. In a new study published in Cancer Cell, they report on key...
14-Apr-2022 11:00 AM EDT Add to Favorites

Moffitt Researchers Identify Immunosuppression as a Key Factor Leading to Colorectal Cancer Development

Moffitt Cancer Center researchers have revealed that the creation of an immunosuppressive environment is key to the progression of benign colorectal adenomas to invasive, malignant carcinomas. Their findings were published in Nature Communications.
7-Apr-2022 9:00 AM EDT Add to Favorites

SpaceX to Take Moffitt Investigators’ Experiment to the International Space Station

Drs. Patsy McDonald and Derek Duckett, Moffitt Cancer Center faculty members and founders of Cadw Therapeutics, are sending a scientific experiment to space. The self-contained experiment will blast off Wednesday, April 6, as a part of Axiom...
30-Mar-2022 10:00 AM EDT Add to Favorites